Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Taylor F et al. – CC represents a treatment option for men with hypogonadism, demonstrating biochemical and clinical efficacy with few side effects and lower cost as compared with TGRT.

Related Articles

Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09    Relevance Score: 67%

Hypogonadism Risk in Men Treated for Childhood Cancer
Journal of Clinical Endocrinology and Metabolism, 10/12/09    Relevance Score: 66%

Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism
Pituitary, 10/29/09    Relevance Score: 64%

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09    Relevance Score: 64%

High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity
Journal of Clinical Endocrinology and Metabolism, 10/21/09    Relevance Score: 45%

Today in Clinical Pharmacology...keeping you current

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/09/09

Predictors of gastroduodenal erosions in patients taking low-dose aspirin
Alimentary Pharmacology and Therapeutics, 12/09/09

Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis
Anti-Cancer Drugs, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address